Dr. Shuch is completing a urologic oncology fellowship at the National Cancer Institute. He is a graduate of the University of Michigan and received his MD from New York University before completing his urology residency and surgery internship at the University of California - Los Angeles.
Dr. Shuch's clinical interest is in the multidisciplinary management of sporadic and hereditary forms of kidney cancer. He will work with the Yale Cancer Center Genetic Counseling Office to care for high-risk renal cell carcinoma (RCC) patients. In addition, he will be working with Drs. Harriet Kluger and Mario Sznol on the development of a multidisciplinary RCC program to develop novel therapies and to offer neoadjuvant and adjuvant clinical trials for patients with RCC.